This UKRI Challenge Fund investment will recruit up to five million volunteers who have agreed to help in a health project that will track their health records and potentially invite them to join further research studies.
This programme holds a major role in supporting the development of new biological processes, strains of organisms and feedstocks. These can be used to support:
- novel, bio-based and low carbon manufacturing processes
- the production of more sustainable products
- the development of remediation processes.
Accelerate the green economy by supporting research and innovation that unlock solutions essential to achieving net zero in the UK by 2050.
Strengthen security and resilience, from individual to national level, across a range of social and economic areas at the heart of daily life.
Innovate UK supports the development of new approaches in a range of technologies including advanced manufacturing, artificial intelligence, digital, electronics, sensors, biosciences, quantum, and advanced computing.
The aim of the CERAF programme is to establish a climate and environmental risk analytics capability and capacity in the UK that will:
- meet the specific needs of the financial services sector
- enhance the resilience of the financial system to the increasing impact of climate change.
The challenge provides funding for commercialising products and technologies based on quantum science.
It builds on the UK National Quantum Technologies Programme (NQTP) to drive innovation across sectors including automotive, healthcare, infrastructure, telecommunications, cybersecurity and defence.
Improve outcomes for people and places across the UK by identifying solutions that promote economic and social prosperity.
The Creative Catalyst offers funding and a package of tailored non-financial support for high-potential micro and small businesses that either:
- are from the creative industries
- support the creative industries
The programme will de-risk innovation in the creative industries and help businesses to grow.
This investment is supporting the development of precision medicine for improved early diagnosis and treatment of common life-changing diseases.
By funding UK businesses and academia, the challenge aims to accelerate the use of research and health data, delivering better health and economic growth.